Cancer immunotherapy using dendritic cell-derived exosomes

Medicina

Volumn 60, Issue SUPPL. 2, 2000, Pages 51-54

  Amigorena, Sebastian ^a  

^a INSTITUT CURIE   (France)

Author keywords

Antigen presentation; Cancer; Dendritic cells; Exosomes; Immunotherapy

Indexed keywords

CD8 ANTIGEN; CELL ADHESION MOLECULE; MAJOR HISTOCOMPATIBILITY ANTIGEN; PROTEOME; TUMOR PROTEIN;

ANTIGEN PRESENTING CELL; ANTINEOPLASTIC ACTIVITY; CANCER IMMUNOTHERAPY; CONFERENCE PAPER; CYTOTOXIC T LYMPHOCYTE; DENDRITIC CELL; ENDOCYTOSIS; ENDOSOME; IMMUNOCYTOTOXICITY; IN VIVO STUDY; MEMBRANE VESICLE; NONHUMAN; SPLEEN;

ANIMALS; ANTIGEN PRESENTATION; CYTOPLASMIC VESICLES; DENDRITIC CELLS; ENDOSOMES; HUMANS; IMMUNOTHERAPY; MICE; NEOPLASMS;

EID: 0033765934     PISSN: 00257680     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (11)

1. Boon T, Old LJ. Cancer tumor antigens. Curr Opin Immunol 1997; 9: 681-3.
2. Banchereau J, Steinman RM. Dendritic cells and the control of immunity. Nature 1998; 392: 245-52.
3. Fernandez N, Duffour MT, Perricaudet M, Lotze MT, Tursz T, Zitvogel L. Active specific T-cell-based immunotherapy for cancer: nucleic acids, peptides, whole native proteins, recombinant viruses, with dendritic cell adjuvants or whole tumor cell-based vaccines. Principles and future prospects. Cytokines Cell Mol Ther 1998; 4: 53-65.
4. Nestle FO, Alijagic S, Gilliet M, et al. Vaccination of melanoma patients with peptide-or tumor lysate-pulsed dendritic cells (see comments). Nature Med 1998; 4: 328-32.
5. Murphy GP, Tjoa BA, Simmons SJ. Phase II prostate cancer vaccine trial: report of a study involving 37 patients with disease recurrence following primary treatment. Prostate 1999; 39: 54-9.
6. Thurner B, Haendle I, Roder C, et al. Vaccination with mage-3A1 peptide-pulsed mature, monocyte-derived dendritic cells expands specific cytotoxic T cells and induces regression of some metastases in advanced stage IV melanoma. J Exp Med 1999; 190: 1669-78.
7. Kugler A, Stuhler G, Walden P, et al. Regression of human metastatic renal cell carcinoma after vaccination with tumor cell-dendritic cell hybrids (see comments). Nature Med 2000; 6: 332-6.
8. Johnstone RM. Maturation of reticulocytes: formation of exosomes as a mechanism for shedding membrane proteins. Biochem Cell Biol 1992; 70: 179-90.
9. Raposo G, Nijman HW, Stoorvogel W, et al. B lymphocytes secrete antigen-presenting vesicles. J Exp Med 1996; 183: 1161-72.
10. Zitvogel L, Regnault A, Lozier A, et al. Eradication of established murine tumors using a novel cell-free vaccine: dendritic cell-derived exosomes. Nature Med 1998; 4: 594-600.
11. Thery C, Regnault A, Garin J, et al. Molecular characterization of dendritic cell-derived exosomes. Selective accumulation of the heat shock protein hsc73. J Cell Biol 1999; 147: 599-610.